FREE Account Opening + No Clearing Fees
Loading...

Global Health IPO vs Kaynes Technology IPO

Comparision between Global Health IPO and Kaynes Technology IPO.

IPO Details

Global Health IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Kaynes Technology IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Global Health IPO is up to ₹2,205.57 Cr whereas the issue size of the Kaynes Technology IPO is up to ₹857.82 Cr. The final issue price of Global Health IPO is ₹336.00 per share and of Kaynes Technology IPO is ₹587.00 per share.

  Global Health IPO Kaynes Technology IPO
Face Value ₹2 per share ₹10 per share
Issue Price (Lower) ₹319.00 per share ₹559.00 per share
Issue Price (Upper) ₹336.00 per share ₹587.00 per share
Issue Price (Final) ₹336.00 per share ₹587.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 44 shares 25 shares
Fresh Issue Size
Fresh Issue Size (Amount) up to ₹500.00 Cr up to ₹530.00 Cr
OFS Issue Size 5,07,61,000 shares 55,84,664 shares
OFS Issue Size (Amount) up to ₹1,705.57 Cr up to ₹327.82 Cr
Issue Size Total
Issue Size Total (Amount) up to ₹2,205.57 Cr up to ₹857.82 Cr

IPO Timetable

Global Health IPO opens on Nov 03, 2022, while Kaynes Technology IPO opens on Nov 10, 2022. The closing date of Global Health IPO and Kaynes Technology IPO is Nov 07, 2022, and Nov 14, 2022, respectively.

  Global Health IPO Kaynes Technology IPO
Anchor Bid Date
Issue Open Nov 03, 2022 Nov 10, 2022
Issue Close Nov 07, 2022 Nov 14, 2022
Basis Of Allotment (Tentative) Nov 11, 2022 Nov 17, 2022
Initiation of Refunds (Tentative) Nov 14, 2022 Nov 18, 2022
Credit of Share (Tentative) Nov 15, 2022 Nov 21, 2022
Listing date (Tentative) Nov 16, 2022 Nov 22, 2022
Anchor Lockin End date 1 Dec 11, 2022 Dec 17, 2022
Anchor Lockin End date 2 Feb 09, 2023 Feb 15, 2023

Financials

Global Health IPO P/E ratio is 38.36, as compared to Kaynes Technology IPO P/E ratio of 84.95.

  Global Health IPO Kaynes Technology IPO
Financial
Global Health Limited Financial Information (Restated)
Period EndedTotal AssetsTotal RevenueProfit After TaxNet WorthTotal Borrowing
31-Mar-202666.291544.2736.331349.54621.94
30-Jun-202855.11491.5841.761425.38725.07
31-Mar-212694.11478.1628.81382.34644.6
31-Mar-223145.522205.82196.21616.01837.86
30-Jun-223221.94626.5458.711675.55794.45
Amount in ₹ Crore
Kaynes Technology India Ltd Financial Information (Restated)
Period EndedTotal AssetsTotal RevenueProfit After TaxNet WorthTotal Borrowing
31-Mar-20378.12370.179.3695.76143.83
31-Mar-21419.37424.669.73136.51139.47
31-Mar-22622.42710.3541.68201.82169.55
30-Jun-22763.26199.9810.05212186.38
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue) 35% 79.78%
Promoter Shareholding (Post-Issue) 33% 67.39%
P/E Ratio 38.36 84.95
Market Cap ₹9011.01 Cr. ₹3412.97 Cr.
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Global Health IPO retail investors (RII) are offered 2,32,52,244 shares while in Kaynes Technology IPO retail investors are offered 2,32,52,244 shares. Qualified institutional buyers (QIB) are offered 1,35,24,905 shares in Global Health IPO and 29,23,888 shares in Kaynes Technology IPO.

  Global Health IPO Kaynes Technology IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB 1,35,24,905 shares 29,23,888 shares
NII 99,65,248 shares 22,55,858 shares
RII 2,32,52,244 shares 52,63,667 shares
Employee 0 shares 26,833 shares
Others
Total 4,67,42,397 shares 1,04,70,246 shares

Bids Received (Subscription)

Global Health IPO subscribed 9.58x in total, whereas Kaynes Technology IPO subscribed 34.16x.

  Global Health IPO Kaynes Technology IPO
QIB (times) 28.64x 98.47x
NII (times) 4.02x 21.21x
Big NII (times) 5.16x 23.07x
Small NII (times) 1.73x 17.47x
RII (times) 0.88x 4.10x
Employee (times) 11.92x
Other (times)
Total (times) 9.58x 34.16x

Comments

Add a public comment...